Fourth Universal Definition of Myocardial Infarction (2018).

[1]  Mario Plebani,et al.  What to do when you question cardiac troponin values , 2018, European heart journal. Acute cardiovascular care.

[2]  A. Jaffe,et al.  How is cardiac troponin released from injured myocardium? , 2018, European heart journal. Acute cardiovascular care.

[3]  S. Meex,et al.  Elevated Cardiac Troponin T in Skeletal Myopathies: Skeletal TnT Cross-Reactivity and/or Cardiac TnT Expression? , 2018, Journal of the American College of Cardiology.

[4]  J. Spertus,et al.  Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document , 2018, Circulation.

[5]  J. Spertus,et al.  Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document , 2018, European heart journal.

[6]  J. Canty,et al.  Troponin Release and Reversible Left Ventricular Dysfunction After Transient Pressure Overload. , 2018, Journal of the American College of Cardiology.

[7]  Johannes Schmid,et al.  Elevated Cardiac Troponin T in Patients With Skeletal Myopathies. , 2018, Journal of the American College of Cardiology.

[8]  A. Jaffe,et al.  The prognostic impact of periprocedural myocardial infarction and injury , 2018, European heart journal.

[9]  G. Helft,et al.  Periprocedural myocardial infarction and injury in elective coronary stenting , 2018, European heart journal.

[10]  James E. Tcheng,et al.  2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials , 2018, Circulation.

[11]  F. Apple,et al.  High-sensitivity cardiac troponin assays and unstable angina , 2018, European heart journal. Acute cardiovascular care.

[12]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[13]  K. Thygesen,et al.  Different Causes of Death in Patients with Myocardial Infarction Type 1, Type 2, and Myocardial Injury. , 2017, The American journal of medicine.

[14]  M. Seeberger,et al.  Perioperative Myocardial Injury After Noncardiac Surgery: Incidence, Mortality, and Characterization , 2017, Circulation.

[15]  D. Newby,et al.  Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury , 2017, Circulation.

[16]  T. Renné,et al.  Discrimination of patients with type 2 myocardial infarction , 2017, European heart journal.

[17]  M. Gulati,et al.  Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry–GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With the Guidelines) , 2017, Circulation. Cardiovascular quality and outcomes.

[18]  J. Januzzi,et al.  The Many Faces of Type 2 Myocardial Infarction. , 2017, Journal of the American College of Cardiology.

[19]  A. Goyal,et al.  What's in a Name? The New ICD-10 (10th Revision of the International Statistical Classification of Diseases and Related Health Problems) Codes and Type 2 Myocardial Infarction. , 2017, Circulation.

[20]  R. Twerenbold,et al.  Clinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction. , 2017, Journal of the American College of Cardiology.

[21]  N. Al-Attar,et al.  ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Peri-operative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery , 2017, European heart journal.

[22]  K. Thygesen,et al.  Incidence, Frequency, and Clinical Characteristics of Type 3 Myocardial Infarction in Clinical Practice. , 2017, The American journal of medicine.

[23]  O. Hammarsten,et al.  Clearance of cardiac troponin T with and without kidney function. , 2017, Clinical biochemistry.

[24]  Sonu Gupta,et al.  Type 2 versus type 1 myocardial infarction: a comparison of clinical characteristics and outcomes with a meta-analysis of observational studies. , 2017, Cardiovascular diagnosis and therapy.

[25]  D. Morrow.  Clinician’s Guide to Early Rule-Out Strategies With High-Sensitivity Cardiac Troponin , 2017, Circulation.

[26]  Pavel S. Roshanov,et al.  Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery , 2017, JAMA.

[27]  Ò. Miró,et al.  Direct Comparison of 4 Very Early Rule-Out Strategies for Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin I , 2017, Circulation.

[28]  Joanna M. Young,et al.  Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection: A Collaborative Meta-analysis. , 2017, Annals of internal medicine.

[29]  B. Lindahl,et al.  Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease , 2017, Circulation.

[30]  A. Jaffe,et al.  Rapid rule out of acute myocardial infarction: novel biomarker-based strategies , 2017, European heart journal. Acute cardiovascular care.

[31]  A. Jaffe,et al.  Editor’s Choice-Rule-in of acute myocardial infarction: Focus on troponin , 2017, European heart journal. Acute cardiovascular care.

[32]  J. Canty,et al.  Brief Myocardial Ischemia Produces Cardiac Troponin I Release and Focal Myocyte Apoptosis in the Absence of Pathological Infarction in Swine , 2017, JACC. Basic to translational science.

[33]  D. Atar,et al.  ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. , 2016, European heart journal.

[34]  C. Herzog,et al.  Interpreting Cardiac Biomarkers in the Setting of Chronic Kidney Disease. , 2017, Clinical chemistry.

[35]  B. Lindahl,et al.  Application of Cardiac Troponin in Cardiovascular Diseases Other Than Acute Coronary Syndrome. , 2017, Clinical chemistry.

[36]  A. Jaffe,et al.  Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care. , 2017, Clinical chemistry.

[37]  P. Tricoci.  Consensus or Controversy?: Evolution of Criteria for Myocardial Infarction After Percutaneous Coronary Intervention. , 2017, Clinical chemistry.

[38]  K. Thygesen,et al.  Myocardial Infarction Type 2 and Myocardial Injury. , 2017, Clinical chemistry.

[39]  Karl-Ludwig Laugwitz,et al.  High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary Intervention. , 2016, Journal of the American College of Cardiology.

[40]  A. Jaffe,et al.  Ruling-In Myocardial Injury and Ruling-Out Myocardial Infarction With the European Society of Cardiology 1-Hour Algorithm , 2016, Circulation.

[41]  K. Iversen,et al.  Prevalence and significance of troponin elevations in patients without acute coronary disease. , 2016, International journal of cardiology.

[42]  A. Bardají,et al.  Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury , 2016, Heart.

[43]  Giuseppe Boriani,et al.  Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy. , 2016, American Journal of Cardiology.

[44]  J. Saw,et al.  Contemporary Review on Spontaneous Coronary Artery Dissection. , 2016, Journal of the American College of Cardiology.

[45]  K. Thygesen,et al.  Prognostic Impact of Myocardial Injury Related to Various Cardiac and Noncardiac Conditions. , 2016, The American journal of medicine.

[46]  F. Montecucco,et al.  Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments. , 2016, European heart journal.

[47]  G. Nickenig,et al.  The prognostic value of acute and chronic troponin elevation after transcatheter aortic valve implantation. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[48]  H. White,et al.  Diagnosis of myocardial infarction and prognostic utility of high-sensitivity troponin T after isolated aortic valve replacement ☆ ☆☆ ★ , 2016 .

[49]  K. Thygesen,et al.  Clinical Characteristics and Outcomes of Patients with Myocardial Infarction, Myocardial Injury, and Nonelevated Troponins. , 2016, The American journal of medicine.

[50]  A. Wu,et al.  Prognostic Value of Serial Changes in High-Sensitivity Cardiac Troponin I and T over 3 Months Using Reference Change Values in Hemodialysis Patients. , 2016, Clinical chemistry.

[51]  G. Schaaf,et al.  Elevated Plasma Cardiac Troponin T Levels Caused by Skeletal Muscle Damage in Pompe Disease , 2016, Circulation. Cardiovascular genetics.

[52]  H. Nathoe,et al.  Coronary CT Angiography for Suspected ACS in the Era of High-Sensitivity Troponins: Randomized Multicenter Study. , 2016, Journal of the American College of Cardiology.

[53]  G. Filippatos,et al.  Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology , 2016, European journal of heart failure.

[54]  Sanjiv J. Shah,et al.  Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction , 2016, European journal of heart failure.

[55]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[56]  R. D. de Winter,et al.  Precordial junctional ST-segment depression with tall symmetric T-waves signifying proximal LAD occlusion, case reports of STEMI equivalence. , 2016, Journal of electrocardiology.

[57]  Michael T. Lu,et al.  hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT II Trial. , 2015, JACC. Cardiovascular imaging.

[58]  Jeroen J. Bax,et al.  Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. , 2015, The New England journal of medicine.

[59]  K. Thygesen,et al.  Diagnosis of unstable angina pectoris has declined markedly with the advent of more sensitive troponin assays. , 2015, The American journal of medicine.

[60]  Michael Freese,et al.  Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction , 2015, Circulation.

[61]  A. Jaffe,et al.  Sensitive Troponin Assay and the Classification of Myocardial Infarction , 2015, The American journal of medicine.

[62]  F. Van de Werf,et al.  Evolving therapies for myocardial ischemia/reperfusion injury. , 2015, Journal of the American College of Cardiology.

[63]  R. Dreyer,et al.  Systematic Review of Patients Presenting With Suspected Myocardial Infarction and Nonobstructive Coronary Arteries , 2015, Circulation.

[64]  S. Seliger,et al.  Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction. , 2015, Clinical biochemistry.

[65]  A. Jaffe,et al.  IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. , 2015, Clinical biochemistry.

[66]  P. Collinson,et al.  High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study , 2015, BMJ : British Medical Journal.

[67]  Stephanie Oberfoell.  High-Risk Plaque Detected on Coronary CT Angiography Predicts Acute Coronary Syndromes Independent of Significant Stenosis in Acute Chest Pain: Results from the Romicat-II Trial , 2015 .

[68]  A. Jaffe,et al.  A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2015 .

[69]  A. Jaffe,et al.  2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[70]  B. Lindahl,et al.  Type 2 myocardial infarction in clinical practice , 2014, Heart.

[71]  Zackary Berger,et al.  Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: a systematic review. , 2014, Annals of internal medicine.

[72]  E. Bass,et al.  Prognostic Value of Cardiac Troponin in Patients With Chronic Kidney Disease Without Suspected Acute Coronary Syndrome , 2014, Annals of Internal Medicine.

[73]  Holger Thiele,et al.  Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. , 2014, Journal of the American College of Cardiology.

[74]  B. Lindahl,et al.  Cardiac troponin I levels in patients with non-ST-elevation acute coronary syndrome-the importance of gender. , 2014, American heart journal.

[75]  J. Fleg,et al.  High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: results from the ROMICAT-II trial. , 2014, Journal of the American College of Cardiology.

[76]  B. Lindahl,et al.  Revision of the troponin T release mechanism from damaged human myocardium. , 2014, Clinical chemistry.

[77]  A. Jaffe,et al.  In search for the Holy Grail: Suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care Association , 2014, European heart journal. Acute cardiovascular care.

[78]  B. Lecky,et al.  Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction. , 2014, Journal of the American College of Cardiology.

[79]  R. Virmani,et al.  Mechanisms of Plaque Formation and Rupture , 2014 .

[80]  E. Omerovic,et al.  Takotsubo triggered by acute myocardial infarction: a common but overlooked syndrome? , 2014, Journal of geriatric cardiology : JGC.

[81]  M. Nybo,et al.  Optimal cut-off value for cardiac troponin I in ruling out Type 5 myocardial infarction. , 2014, Interactive cardiovascular and thoracic surgery.

[82]  G. Aurigemma,et al.  Systolic and Diastolic Mechanics in Stress Cardiomyopathy , 2014, Circulation.

[83]  J. Hallas,et al.  Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort. , 2014, The American journal of medicine.

[84]  F. Apple,et al.  The global need to define normality: the 99th percentile value of cardiac troponin. , 2014, Clinical chemistry.

[85]  A. Capucci,et al.  Differences and similarities of repolarization patterns during hospitalization for Takotsubo cardiomyopathy and acute coronary syndrome. , 2013, The American journal of cardiology.

[86]  H. Katus,et al.  Cardiac troponin level elevations not related to acute coronary syndromes , 2013, Nature Reviews Cardiology.

[87]  M. Mack,et al.  Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). , 2013, Journal of the American College of Cardiology.

[88]  S. Dixon,et al.  Angiographic and clinical characteristics of type 1 versus type 2 perioperative myocardial infarction , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[89]  C. Reid,et al.  Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. , 2013, Journal of the American College of Cardiology.

[90]  M. Petzold,et al.  Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality. , 2013, Journal of the American College of Cardiology.

[91]  J. Hallas,et al.  Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. , 2013, The American journal of medicine.

[92]  R. Califf,et al.  The left bundle-branch block puzzle in the 2013 ST-elevation myocardial infarction guideline: from falsely declaring emergency to denying reperfusion in a high-risk population. Are the Sgarbossa Criteria ready for prime time? , 2013, American heart journal.

[93]  H. White,et al.  Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the Universal Definition of MI , 2013, European heart journal. Acute cardiovascular care.

[94]  A. Jaffe,et al.  High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. , 2013, American heart journal.

[95]  C. Granger,et al.  Emergency Department Bypass for ST-Segment–Elevation Myocardial Infarction Patients Identified With a Prehospital Electrocardiogram: A Report From the American Heart Association Mission Lifeline Program , 2013, Circulation.

[96]  C. Vilaplana,et al.  Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men. , 2013, American heart journal.

[97]  A. Jaffe,et al.  Defining high-sensitivity cardiac troponin concentrations in the community. , 2013, Clinical chemistry.

[98]  E. Braunwald,et al.  Unstable Angina: Is It Time for a Requiem? , 2013, Circulation.

[99]  A. Sinha.  Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D). , 2013 .

[100]  K. Klingel,et al.  ECG findings in comparison to cardiovascular MR imaging in viral myocarditis. , 2013, International journal of cardiology.

[101]  M. Seeberger,et al.  Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery. , 2013, European heart journal.

[102]  Erling Falk,et al.  Update on acute coronary syndromes: the pathologists' view. , 2013, European heart journal.

[103]  A. Jaffe,et al.  Diagnostic performance of rising, falling, or rising and falling kinetic changes of high-sensitivity cardiac troponin T in an unselected emergency department population , 2013, European heart journal. Acute cardiovascular care.

[104]  C. Ayers,et al.  Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population. , 2013, Journal of the American College of Cardiology.

[105]  J. Alpert,et al.  How to use high-sensitivity cardiac troponins in acute cardiac care. , 2013, European heart journal.

[106]  S. Kurz,et al.  Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. , 2012, The American journal of medicine.

[107]  P. Moreno,et al.  Angiographic investigation of the pathophysiology of perioperative myocardial infarction , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[108]  Fred S Apple,et al.  Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. , 2012, Clinical chemistry.

[109]  Fred S Apple,et al.  Third universal definition of myocardial infarction , 2012 .

[110]  Jennifer Taylor.  Third universal definition of myocardial infarction. , 2012, European heart journal.

[111]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[112]  A. Richards,et al.  Cardiac biomarker responses to dobutamine stress echocardiography in healthy volunteers and patients with coronary artery disease. , 2012, Clinical chemistry.

[113]  J. Alpert,et al.  How to use high-sensitivity cardiac troponins in acute cardiac care , 2012 .

[114]  A. Donato,et al.  Predictive accuracy of ST depression during rapid atrial fibrillation on the presence of obstructive coronary artery disease. , 2012, The American journal of emergency medicine.

[115]  M. Wolf,et al.  Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. , 2012, Clinical chemistry.

[116]  G. Filippatos,et al.  Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. , 2012, European heart journal.

[117]  J. Fleg,et al.  Coronary CT angiography versus standard evaluation in acute chest pain. , 2012, The New England journal of medicine.

[118]  H. White,et al.  Patients with circumflex occlusions miss out on reperfusion: how to recognize and manage them , 2012, Current opinion in cardiology.

[119]  R. Testa,et al.  Aged-related increase of high sensitive Troponin T and its implication in acute myocardial infarction diagnosis of elderly patients , 2012, Mechanisms of Ageing and Development.

[120]  P. Lemos,et al.  Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous. , 2012, Atherosclerosis.

[121]  G. Guyatt,et al.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012, JAMA.

[122]  A. Folsom,et al.  Twenty-Two–Year Trends in Incidence of Myocardial Infarction, Coronary Heart Disease Mortality, and Case Fatality in 4 US Communities, 1987–2008 , 2012, Circulation.

[123]  Jeroen J. Bax,et al.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2012 .

[124]  O. Hlinomaz,et al.  Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy? , 2011, European heart journal.

[125]  A. Jaffe,et al.  Troponin release--reversible or irreversible injury? Should we care? , 2012, Clinical chemistry.

[126]  P. Collinson,et al.  Influence of population selection on the 99th percentile reference value for cardiac troponin assays. , 2012, Clinical chemistry.

[127]  Hugo A Katus,et al.  Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. , 2012, Clinical chemistry.

[128]  S. Blankenberg,et al.  Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. , 2011, JAMA.

[129]  A. Jaffe,et al.  Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. , 2011, Journal of the American College of Cardiology.

[130]  D. Xavier,et al.  High sensitivity troponin T concentrations in patients undergoing noncardiac surgery: a prospective cohort study. , 2011, Clinical biochemistry.

[131]  R. Twerenbold,et al.  Utility of Absolute and Relative Changes in Cardiac Troponin Concentrations in the Early Diagnosis of Acute Myocardial Infarction , 2011, Circulation.

[132]  A. Wu,et al.  Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. , 2011, Clinical chemistry.

[133]  H. White.  Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? , 2011, Journal of the American College of Cardiology.

[134]  J. Cigarroa,et al.  Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study. , 2011, Journal of the American College of Cardiology.

[135]  Michael Freese,et al.  Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. , 2011, European heart journal.

[136]  Denis Xavier,et al.  Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery , 2011, Annals of Internal Medicine.

[137]  N. Weissman,et al.  A suggested roadmap for cardiovascular ultrasound research for the future. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[138]  H. White,et al.  Utility of cardiac biomarkers for the diagnosis of type V myocardial infarction after coronary artery bypass grafting: insights from serial cardiac MRI , 2011, Heart.

[139]  Kari Kuulasmaa,et al.  World Health Organization definition of myocardial infarction: 2008-09 revision. , 2011, International journal of epidemiology.

[140]  Stephan Achenbach,et al.  Cardiac imaging after myocardial infarction. , 2011, European heart journal.

[141]  H. Katus,et al.  Troponin elevation in coronary vs. non-coronary disease. , 2011, European heart journal.

[142]  D. Jacobs,et al.  The effect of changing diagnostic algorithms on acute myocardial infarction rates. , 2009, Annals of epidemiology.

[143]  James McCord,et al.  Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. , 2010, Circulation.

[144]  Michael Jerosch-Herold,et al.  Assessment of acute myocardial infarction: current status and recommendations from the North American society for cardiovascular imaging and the European society of cardiac radiology , 2010, The International Journal of Cardiovascular Imaging.

[145]  Christopher M O'Connor,et al.  Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. , 2010, Journal of the American College of Cardiology.

[146]  Mario Plebani,et al.  Recommendations for the use of cardiac troponin measurement in acute cardiac care. , 2010, European heart journal.

[147]  D. Pennell,et al.  New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions? , 2010, JACC. Cardiovascular interventions.

[148]  H. White,et al.  aVR ST elevation: an important but neglected sign in ST elevation acute myocardial infarction. , 2010, European heart journal.

[149]  A. Lardo,et al.  Assessment of coronary blood flow with computed tomography and magnetic resonance imaging , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[150]  A. Jaffe,et al.  Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. , 2010, Clinical chemistry.

[151]  A. Hofman,et al.  Unrecognised myocardial infarction and long-term risk of heart failure in the elderly: the Rotterdam Study , 2010, Heart.

[152]  H. Taegtmeyer.  Tracing Cardiac Metabolism In Vivo: One Substrate at a Time , 2010, Journal of Nuclear Medicine.

[153]  Albert J. Sinusas,et al.  Multimodality Imaging of Myocardial Injury and Remodeling , 2010, Journal of Nuclear Medicine.

[154]  B. Scirica,et al.  Acute coronary syndrome: emerging tools for diagnosis and risk assessment. , 2010, Journal of the American College of Cardiology.

[155]  M. Kontos,et al.  Emergency department and office-based evaluation of patients with chest pain. , 2010, Mayo Clinic proceedings.

[156]  A. Jaffe,et al.  Analytical validation of a high-sensitivity cardiac troponin T assay. , 2010, Clinical chemistry.

[157]  A. Beek,et al.  Cardiovascular magnetic resonance imaging in patients with acute myocardial infarction , 2010, Heart.

[158]  P. Toth.  Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study , 2010 .

[159]  M. Cowie,et al.  Cardiac sympathetic imaging with mIBG in heart failure. , 2010, JACC. Cardiovascular imaging.

[160]  M. Laakso,et al.  Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. , 2010, European heart journal.

[161]  R. Kim,et al.  Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. , 2009, Journal of the American College of Cardiology.

[162]  Regina M. Hardison,et al.  The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease: Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction , 2009, Circulation.

[163]  R. Christenson,et al.  Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. , 2009, Clinical chemistry.

[164]  S. Darby,et al.  Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study , 2009, Heart.

[165]  W. Wodzig,et al.  Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays , 2009, Annals of clinical biochemistry.

[166]  Joseph S. Alpert,et al.  Perioperative Myocardial Infarction , 2009, Circulation.

[167]  E. Braunwald,et al.  Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial. , 2009, Journal of the American College of Cardiology.

[168]  D. Kraitchman,et al.  Advances in Cardiovascular Imaging Multimodality Cardiovascular Molecular Imaging, Part II , 2008 .

[169]  R. D. de Winter,et al.  A new ECG sign of proximal LAD occlusion. , 2008, The New England journal of medicine.

[170]  F. Epstein,et al.  Multimodality cardiovascular molecular imaging, part I. , 2008, Circulation. Cardiovascular imaging.

[171]  J. Alpert,et al.  Diagnostic application of the universal definition of myocardial infarction in the intensive care unit , 2008, Current opinion in critical care.

[172]  R. Kwong,et al.  Incidence and Prognostic Implication of Unrecognized Myocardial Scar Characterized by Cardiac Magnetic Resonance in Diabetic Patients Without Clinical Evidence of Myocardial Infarction , 2008, Circulation.

[173]  Bekele Afessa,et al.  Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients , 2008, Critical care medicine.

[174]  I. Kallikazaros,et al.  CorrespondenceResearch CorrespondenceTransient ST-Segment Depression During Paroxysms of Atrial Fibrillation in Otherwise Normal Individuals: Relation With Underlying Coronary Artery Disease , 2007 .

[175]  Jeroen J. Bax,et al.  Universal definition of myocardial infarction. , 2007 .

[176]  K. Eagle,et al.  The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). , 2006, American heart journal.

[177]  W. Lewis.  Echocardiography in the evaluation of patients in chest pain units. , 2005, Cardiology clinics.

[178]  C. Sprung,et al.  Myocardial ischemia, cardiac troponin, and long-term survival of high-cardiac risk critically ill intensive care unit patients* , 2005, Critical care medicine.

[179]  A. Jeremias,et al.  Narrative Review: Alternative Causes for Elevated Cardiac Troponin Levels when Acute Coronary Syndromes Are Excluded , 2005, Annals of Internal Medicine.

[180]  S. Petersen,et al.  Troponin Elevation After Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible Myocardial Injury: Insights From Cardiovascular Magnetic Resonance Imaging , 2005, Circulation.

[181]  B. Maron,et al.  Acute and Reversible Cardiomyopathy Provoked by Stress in Women From the United States , 2005, Circulation.

[182]  F. Apple,et al.  Cardiac troponin and creatine kinase MB monitoring during in-hospital myocardial reinfarction. , 2005, Clinical chemistry.

[183]  Matthew D. Robson,et al.  Effects of Off-Pump Versus On-Pump Coronary Surgery on Reversible and Irreversible Myocardial Injury: A Randomized Trial Using Cardiovascular Magnetic Resonance Imaging and Biochemical Markers , 2004, Circulation.

[184]  L. Becker.  Myocardial Reperfusion Injury , 2004, Journal of Thrombosis and Thrombolysis.

[185]  R. Gibbons,et al.  In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi) , 2004, European Journal of Nuclear Medicine.

[186]  R. Asinger,et al.  ST-segment elevation in conditions other than acute myocardial infarction. , 2003, The New England journal of medicine.

[187]  J S Alpert,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.

[188]  D. Ooi,et al.  Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology. , 2000, Clinical chemistry.

[189]  D Freimark,et al.  Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9: "hidden" ST-segment elevations revealing acute posterior infarction. , 1999, Journal of the American College of Cardiology.

[190]  S. Higano,et al.  Images in cardiovascular medicine. Electrocardiographic diagnosis of acute myocardial infarction during ventricular pacing. , 1998, Circulation.

[191]  D. Freimark,et al.  Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads: V7–9 , 1998 .

[192]  J. Zamorano,et al.  Non-invasive assessment of cardiac physiology by tissue Doppler echocardiography. A comparison with invasive haemodynamics. , 1997, European heart journal.

[193]  G S Wagner,et al.  Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. , 1996, The New England journal of medicine.

[194]  A. Jaffe,et al.  Myocardial injury in critically ill patients : a frequently unrecognized complication , 1995 .

[195]  H. Tunstall-Pedoe,et al.  Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents , 1994, Circulation.

[196]  R. Virmani,et al.  Myocardial reperfusion injury. Histopathological effects of perfluorochemical. , 1990, Circulation.

[197]  S. Barold,et al.  Electrocardiographic diagnosis of myocardial infarction during ventricular pacing. , 1987, Cardiology clinics.

[198]  J. López-Sendón,et al.  Electrocardiographic findings in acute right ventricular infarction: sensitivity and specificity of electrocardiographic alterations in right precordial leads V4R, V3R, V1, V2, and V3. , 1985, Journal of the American College of Cardiology.

[199]  J. Karnegis,et al.  Development and evolution of electrocardiographic Minnesota Q-QS codes in patients with acute myocardial infarction. , 1985, American heart journal.

[200]  R. Jennings,et al.  Pathobiology of acute myocardial ischemia: metabolic, functional and ultrastructural studies. , 1983, The American journal of cardiology.

[201]  H. Wellens,et al.  Characteristic electrocardiographic pattern indicating a critical stenosis high in left anterior descending coronary artery in patients admitted because of impending myocardial infarction. , 1982, American heart journal.

[202]  Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. , 1979, Circulation.

[203]  S. Vatner,et al.  Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. , 1978, The Journal of clinical investigation.

[204]  R. Ideker,et al.  Correlation of Postmortem Anatomic Findings with Electrocardiographic Changes in Patients with Myocardial Infarction: Retrospective Study of Patients with Typical Anterior and Posterior Infarcts , 1977, Circulation.

[205]  R. Jennings,et al.  Structural Changes in Myocardium During Acute Ischemia , 1974, Circulation research.

[206]  L. Horan,et al.  Significance of the Diagnostic Q Wave of Myocardial Infarction , 1971, Circulation.

[207]  H. Horn,et al.  ACUTE MYOCARDIAL INFARCTION NOT DUE TO CORONARY ARTERY OCCLUSION , 1939 .

[208]  J. Herrick.  CLINICAL FEATURES OF SUDDEN OBSTRUCTION OF THE CORONARY ARTERIES , 1912 .

[209]  D. Pennell,et al.  Universal Definition of Myocardial Infarction pplicable After Complex Percutaneous Coronary Interventions ? , 2022 .